CDK4/6 Inhibitors Boost First-Line Breast Cancer Therapy
In an ambitious stride toward optimizing treatment for hormone receptor-positive (HR+)/HER2-negative advanced breast cancer, a recent comprehensive network meta-analysis has ...
Tag: hormone receptor-positive breast cancer
Ovarian Suppression Benefits in Early Breast Cancer
In a groundbreaking multi-center retrospective study published in BMC Cancer, researchers have unveiled compelling evidence supporting the use of a ...
Understanding Why Certain Breast Cancer Therapies Lose Effectiveness
Breast cancer remains a significant global health challenge, impacting millions of women across different cultures and demographics. Recent findings from ...
University of Oklahoma Study Reveals Increased Mortality Risk for Specific Breast Cancer Subtypes with Surgery Delays Exceeding 42 Days
Patients diagnosed with specific subtypes of breast cancer may face significant risks if surgical treatment is delayed beyond 42 days ...
RSClin® Tool N+ Enhances Accuracy in Recurrence Risk Estimation and Chemotherapy Benefit for Node-Positive Breast Cancer
A groundbreaking statistical tool has emerged that enhances the ability to predict breast cancer prognosis and treatment response for patients ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!